Loss of


Journal

Science advances
ISSN: 2375-2548
Titre abrégé: Sci Adv
Pays: United States
ID NLM: 101653440

Informations de publication

Date de publication:
04 02 2022
Historique:
entrez: 4 2 2022
pubmed: 5 2 2022
medline: 20 4 2022
Statut: ppublish

Résumé

Tuberous sclerosis complex subunit 1 (

Identifiants

pubmed: 35119931
doi: 10.1126/sciadv.abi9533
pmc: PMC8816329
doi:

Substances chimiques

B7-H1 Antigen 0
Immune Checkpoint Inhibitors 0
TSC1 protein, human 0
TSC2 protein, human 0
Tsc2 protein, mouse 0
Tuberous Sclerosis Complex 1 Protein 0
Tuberous Sclerosis Complex 2 Protein 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

eabi9533

Subventions

Organisme : NCI NIH HHS
ID : P50 CA101942
Pays : United States

Références

Cancer Res. 2016 Jan 15;76(2):227-38
pubmed: 26637667
Cell. 2006 Sep 8;126(5):955-68
pubmed: 16959574
Cancer Discov. 2020 Feb;10(2):270-287
pubmed: 31744829
Eur J Immunol. 2003 Oct;33(10):2706-16
pubmed: 14515254
Oncoimmunology. 2018 Jun 20;7(12):e1396403
pubmed: 30524878
Sci Rep. 2018 Jun 15;8(1):9227
pubmed: 29907753
Nat Rev Cancer. 2009 Aug;9(8):563-75
pubmed: 19629071
J Clin Oncol. 2018 Mar 1;36(7):633-641
pubmed: 29337640
Immunity. 2017 Dec 19;47(6):1083-1099.e6
pubmed: 29246442
Nat Cell Biol. 2018 Mar;20(3):320-331
pubmed: 29403037
Cell Signal. 2003 Aug;15(8):729-39
pubmed: 12781866
Cancer J. 2014 Jul-Aug;20(4):256-61
pubmed: 25098285
Cell. 2017 Mar 9;168(6):960-976
pubmed: 28283069
J Natl Cancer Inst. 2015 Nov 17;108(1):
pubmed: 26577528
Nat Med. 2018 Sep;24(9):1441-1448
pubmed: 30082870
Mol Cell. 2012 Aug 24;47(4):535-46
pubmed: 22795129
Cancer Cell. 2018 May 14;33(5):843-852.e4
pubmed: 29657128
Cancer Discov. 2013 Aug;3(8):870-9
pubmed: 23715154
Nat Commun. 2016 Feb 17;7:10501
pubmed: 26883990
Nature. 2017 Jan 18;541(7637):321-330
pubmed: 28102259
Mol Cell. 2002 Jul;10(1):151-62
pubmed: 12150915
Cancer Discov. 2013 Dec;3(12):1355-63
pubmed: 24078774

Auteurs

Qingyuan Huang (Q)

Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.
Institute of Thoracic Oncology, Fudan University, Shanghai, China.

Fei Li (F)

Department of Pathology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

Hai Hu (H)

Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.

Zhaoyuan Fang (Z)

State Key Laboratory of Cell Biology, Innovation Center for Cell Signaling Network, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, China.

Zhendong Gao (Z)

Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.
Institute of Thoracic Oncology, Fudan University, Shanghai, China.

Guozhan Xia (G)

Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.
Institute of Thoracic Oncology, Fudan University, Shanghai, China.

Wai-Lung Ng (WL)

School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong, Sha Tin, Hong Kong SAR, China.

Alireza Khodadadi-Jamayran (A)

Applied Bioinformatics Laboratories and Genome Technology Center, Division of Advanced Research Technologies, New York University Langone Medical Center, New York, NY, USA.

Ting Chen (T)

Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.

Jiehui Deng (J)

Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.

Hua Zhang (H)

Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.

Christina Almonte (C)

Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.

Kristen Labbe (K)

Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.

Han Han (H)

Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.

Ke Geng (K)

Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.

Sittinon Tang (S)

Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.

Gordon J Freeman (GJ)

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Yuan Li (Y)

Department of Pathology, Fudan University Shanghai Cancer Center, Shanghai, China.

Haiquan Chen (H)

Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.
Institute of Thoracic Oncology, Fudan University, Shanghai, China.

Kwok-Kin Wong (KK)

Laura and Isaac Perlmutter Cancer Center, New York University Grossman School of Medicine, NYU Langone Health, New York, NY, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH